The following drugs selectively inhibit the reuptake of the 5-HT (SSRI, such as Escitalopram and Fluoxetine), both 5-HT and NA (SNRI, such as Venlafaxine and Duloxetine), NE only (NRI, such Reboxetine), NE and DA (NDRI, such as Bupropion), or other multi-receptors drugs as noradrenergic and specific serotoninergic antidepressant (Nassa, such as Mirtazapine and Mianserine) or 5-HT antagonist and reuptake inhibitors (SARI, such as Vortioxetine and Trazodone)